Grifols (GIKLY) Interest Coverage Ratio Growth (3y) (2013 - 2018)
Grifols (GIKLY) Interest Coverage Ratio Growth (3y) (2013 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Eli Lilly |
1,066.16 Bn |
1,060.88 Bn |
16.22 Bn |
- |
| 2 |
Johnson & Johnson |
611.69 Bn |
589.64 Bn |
15.96 Bn |
-4.62% |
| 3 |
AbbVie |
444.34 Bn |
434.99 Bn |
10.78 Bn |
- |
| 4 |
Astrazeneca |
284.94 Bn |
277.05 Bn |
12.61 Bn |
-15.66% |
| 5 |
Merck |
224.23 Bn |
218.58 Bn |
12.09 Bn |
- |
| 6 |
Amgen |
195.12 Bn |
183.08 Bn |
5.87 Bn |
4.68% |
| 7 |
Gilead Sciences |
156.45 Bn |
148.73 Bn |
5.52 Bn |
13.28% |
| 8 |
Pfizer |
136.01 Bn |
123.24 Bn |
-1.21 Bn |
- |
| 9 |
Novartis Ag |
113.45 Bn |
113.67 Bn |
- |
- |
| 10 |
Grifols |
- |
- |
- |
- |
| Date | Value |
|---|
| Jun 30, 2018 |
-2.83% |
| Dec 31, 2017 |
5.95% |
| Jun 30, 2017 |
-98.96% |
| Dec 31, 2016 |
-28.18% |
| Sep 30, 2016 |
6.81% |
| Jun 30, 2016 |
6.07% |
| Mar 31, 2016 |
-46.63% |
| Dec 31, 2015 |
71.02% |
| Sep 30, 2015 |
19.55% |
| Jun 30, 2015 |
17.43% |
| Mar 31, 2015 |
22.80% |
| Dec 31, 2014 |
111.55% |
| Sep 30, 2014 |
33.18% |
| Jun 30, 2014 |
7,744.61% |
| Mar 31, 2014 |
31.08% |
| Dec 31, 2013 |
84.25% |
| Sep 30, 2013 |
30.79% |
